This topic contains a solution. Click here to go to the answer

Author Question: The reader is acquainted with the research problem in which section of the report? A) ... (Read 196 times)

Starlight

  • Hero Member
  • *****
  • Posts: 567
The reader is acquainted with the research problem in which section of the report?
 
  A) Introduction
  B) Methods
  C) Results
  D) Discussion

Question 2

When there are multiple authors of a report, what is the corresponding author?
 
  A) Always listed as the first author
  B) Is the person whose name is first alphabetically
  C) Is the individual who has overall responsibility for the manuscript
  D) Author with whom the journal communicates



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meganlapinski

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

A

Answer to Question 2

D




Starlight

  • Member
  • Posts: 567
Reply 2 on: Jul 8, 2018
Great answer, keep it coming :)


AISCAMPING

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library